ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Stifel Financial Corp

Stifel Financial Corp decreased its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 19.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,454 shares of the medical instruments supplier’s stock after selling 828 shares during the period. Stifel Financial Corp’s holdings in ICU Medical were worth $629,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ICUI. Dimensional Fund Advisors LP raised its stake in shares of ICU Medical by 21.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier’s stock worth $36,996,000 after buying an additional 55,588 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in ICU Medical by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock worth $54,868,000 after acquiring an additional 27,927 shares during the period. WCM Investment Management LLC raised its position in ICU Medical by 1.3% in the third quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier’s stock worth $45,272,000 after acquiring an additional 3,407 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in ICU Medical by 11.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 216,509 shares of the medical instruments supplier’s stock valued at $25,710,000 after acquiring an additional 22,310 shares during the last quarter. Finally, Federated Hermes Inc. boosted its position in shares of ICU Medical by 9.3% during the 2nd quarter. Federated Hermes Inc. now owns 215,808 shares of the medical instruments supplier’s stock valued at $25,627,000 after purchasing an additional 18,301 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Trading Up 1.4 %

NASDAQ:ICUI opened at $156.89 on Thursday. The stock has a market cap of $3.84 billion, a PE ratio of -34.33 and a beta of 0.62. ICU Medical, Inc. has a fifty-two week low of $86.80 and a fifty-two week high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock’s 50-day moving average is $167.36 and its two-hundred day moving average is $154.03.

Analyst Ratings Changes

ICUI has been the topic of a number of research reports. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a report on Wednesday, December 11th. Raymond James upped their price target on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. KeyCorp boosted their target price on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $199.67.

Insider Buying and Selling at ICU Medical

In other news, Director David C. Greenberg sold 972 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the completion of the sale, the director now directly owns 5,037 shares of the company’s stock, valued at $796,400.07. This trade represents a 16.18 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $17,973,261.12. This represents a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 40,364 shares of company stock worth $6,869,878. 6.70% of the stock is currently owned by company insiders.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.